| Daunorubicin | Approved Investigational | RB1 | 5925 |
upregulated | Daunorubicin results in increased expression of RB1 mRNA | 13q14.2 | |
| Daunorubicin | Approved Investigational | RBBP6 | 5930 |
upregulated | Daunorubicin results in increased expression of RBBP6 mRNA | 16p12.1 | |
| Daunorubicin | Approved Investigational | RYR2 | 6262 |
downregulated | Daunorubicin results in decreased expression of RYR2 mRNA | 1q43 | |
| Daunorubicin | Approved Investigational | SCN2B | 6327 |
downregulated | Daunorubicin results in decreased expression of SCN2B mRNA | 11q23.3 | |
| Daunorubicin | Approved Investigational | SCN5A | 6331 |
downregulated | Daunorubicin results in decreased expression of SCN5A mRNA | 3p22.2 | |
| Daunorubicin | Approved Investigational | SDC1 | 6382 |
upregulated | Daunorubicin results in increased expression of SDC1 mRNA | 2p24.1 | |
| Daunorubicin | Approved Investigational | SERPINE1 | 5054 |
downregulated | Daunorubicin results in decreased expression of SERPINE1 mRNA | 7q22.1 | |
| Daunorubicin | Approved Investigational | SMPD1 | 6609 |
upregulated | Daunorubicin results in increased expression of SMPD1 mRNA | 11p15.4 | |
| Daunorubicin | Approved Investigational | SMPD3 | 55512 |
upregulated | Daunorubicin results in increased expression of SMPD3 mRNA | 16q22.1 | |
| Daunorubicin | Approved Investigational | TAP1 | 6890 |
upregulated | Daunorubicin results in increased expression of TAP1 mRNA | 6p21.32 | |
| Daunorubicin | Approved Investigational | TAX1BP3 | 30851 |
upregulated | Daunorubicin results in increased expression of TAX1BP3 mRNA | 17p13.2 | |
| Daunorubicin | Approved Investigational | TNFSF9 | 8744 |
upregulated | Daunorubicin results in increased expression of TNFSF9 mRNA | 19p13.3 | |
| Daunorubicin | Approved Investigational | TNNT1 | 7138 |
downregulated | Daunorubicin results in decreased expression of TNNT1 mRNA | 19q13.4 | |
| Daunorubicin | Approved Investigational | TP53 | 7157 |
upregulated | Daunorubicin results in increased expression of TP53 mRNA | 17p13.1 | |
| Daunorubicin | Approved Investigational | TP53I3 | 9540 |
upregulated | Daunorubicin results in increased expression of TP53I3 mRNA | 2p23.3 | |
| Daunorubicin | Approved Investigational | TP53TG1 | 11257 |
upregulated | Daunorubicin results in increased expression of TP53TG1 mRNA | 7q21.12 | |
| Daunorubicin | Approved Investigational | ZMAT3 | 64393 |
upregulated | Daunorubicin results in increased expression of ZMAT3 mRNA | 3q26.32 | |
| Capric acid | Investigational | PPARGC1A | 10891 |
upregulated | decanoic acid results in increased expression of PPARGC1A mRNA | 4p15.2 | |
| Decitabine | Approved Investigational | ABCC1 | 4363 |
upregulated | decitabine results in increased expression of ABCC1 mRNA | 16p13.11 | |
| Decitabine | Approved Investigational | ABCC2 | 1244 |
upregulated | decitabine results in increased expression of ABCC2 mRNA | 10q24.2 | |
| Decitabine | Approved Investigational | ABCC3 | 8714 |
upregulated | decitabine results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Decitabine | Approved Investigational | ABCC5 | 10057 |
upregulated | decitabine results in increased expression of ABCC5 mRNA | 3q27.1 | |
| Decitabine | Approved Investigational | ABHD18 | 80167 |
downregulated | decitabine results in decreased expression of ABHD18 mRNA | 4q28.2 | |
| Decitabine | Approved Investigational | ACADVL | 37 |
upregulated | decitabine results in increased expression of ACADVL mRNA | 17p13.1 | |
| Decitabine | Approved Investigational | ACSL3 | 2181 |
upregulated | decitabine results in increased expression of ACSL3 mRNA | 2q36.1 | |